Holdings

Great Point Partners LLC

As of Sep 30, 2026, Great Point Partners LLC reported 37 positions worth US$343M. Largest: Vera Therapeutics, Inc., Vor Biopharma Inc. and Amylyx Pharmaceuticals, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Vera Therapeutics, Inc.809KUS$26.1M+208KSep 30, 2026
Vor Biopharma Inc.1.13MUS$21.5M−573KSep 30, 2026
Amylyx Pharmaceuticals, Inc.700KUS$20.4Mno changeSep 30, 2026
Sagimet Biosciences Inc. - Series A1.96MUS$19.4M−68,232Sep 30, 2026
Definium Therapeutics, Inc.509KUS$19.4M+83,735Sep 30, 2026
Ionis Pharmaceuticals, Inc.420KUS$18.8MnewSep 30, 2026
Genmab A/S525KUS$18.7MnewSep 30, 2026
Zura Bio Limited4.08MUS$17M−139KSep 30, 2026
LB Pharmaceuticals Inc410KUS$15.8M+93,199Sep 30, 2026
Abivax SA155KUS$15.3M−49,314Sep 30, 2026